Skip to content

Nutex Health Inc. NUTX Finance Lease, Right-of-Use Asset, after Accumulated Amortization

Finance Lease, Right-of-Use Asset, after Accumulated Amortization at other companies

The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG

Other financials

Income statement

See full
Revenue$216.5M+2.2%
Gross profit$91.7M-22.5%
Operating income$81.3M+0.7%
Net income$46.8M+121%
EPS (diluted)$6.52+95.8%

Balance sheet

See full
Cash & equivalents$210.6M+149%
Total debt$348.9M+4.4%
Total equity$346.3M+75.7%
Total assets$957.3M+25.6%

Cash flow

See full
Operating cash flow$75.5M+48.2%
CapEx$1.2M+1,777%
Free cash flow$74.3M+46.0%

Valuation

See full
Market cap$1.02B+62.2%
Enterprise value$1.15B+32.0%
P/E10.5×+2.0×
P/S1.2×+0.2×

Profitability

See full
Gross margin47.5%-1.3pp
Operating margin31.4%-2.2pp
Net margin11%-0.9pp
FCF margin30.6%+19.4pp

Returns & leverage

See full
Return on equity35.5%-21.2pp
Debt / equity-0.7×
Current ratio3.1×+0.9×

Where this comes from

Reported directly by Nutex Health Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseRightOfUseAsset.

The official record: Nutex Health Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nutex Health Inc.'s finance lease, right-of-use asset, after accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nutex Health Inc.'s finance lease, right-of-use asset, after accumulated amortization?
Nutex Health Inc. (NUTX) reported finance lease, right-of-use asset, after accumulated amortization of $220.7M in Q1 2026.
How has Nutex Health Inc.'s finance lease, right-of-use asset, after accumulated amortization changed year-over-year?
Nutex Health Inc.'s finance lease, right-of-use asset, after accumulated amortization increased by 2.1% year-over-year, from $216.19M to $220.7M.
What is the long-term trend for Nutex Health Inc.'s finance lease, right-of-use asset, after accumulated amortization?
Over 4 years (2021 to 2025), Nutex Health Inc.'s finance lease, right-of-use asset, after accumulated amortization has grown at a 36.2% compound annual growth rate (CAGR), from $64.61M to $222.37M.